Hospital management company Universal Health Services (NYSE:UHS) will be announcing earnings results this Monday after market hours. Here’s what you need to know.
Universal Health Services missed analysts’ revenue expectations by 1% last quarter, reporting revenues of $4.1 billion, up 6.7% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ EPS estimates but same-store sales in line with analysts’ estimates.
Is Universal Health Services a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Universal Health Services’s revenue to grow 8.6% year on year to $4.24 billion, slowing from the 10.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $4.94 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Universal Health Services has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Universal Health Services’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Tenet Healthcare delivered year-on-year revenue growth of 3.3%, beating analysts’ expectations by 2.3%, and HCA Healthcare reported revenues up 6.4%, topping estimates by 0.7%. Tenet Healthcare traded down 9.4% following the results.
Read our full analysis of Tenet Healthcare’s results here and HCA Healthcare’s results here.
Investors in the healthcare providers & services segment have had steady hands going into earnings, with share prices flat over the last month. Universal Health Services is down 10.9% during the same time and is heading into earnings with an average analyst price target of $224.38 (compared to the current share price of $158.71).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.